ONO Stock Overview
onesano S.A. engages in the research and development in the areas of dietetics, animal nutrition, bioremediation, and agrotechnological processes in Poland.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
onesano S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł1.35 |
52 Week High | zł2.00 |
52 Week Low | zł1.10 |
Beta | 0.76 |
1 Month Change | -8.78% |
3 Month Change | 12.03% |
1 Year Change | 12.50% |
3 Year Change | -66.00% |
5 Year Change | 58.82% |
Change since IPO | -90.75% |
Recent News & Updates
Shareholder Returns
ONO | PL Food | PL Market | |
---|---|---|---|
7D | -2.2% | -0.9% | 2.3% |
1Y | 12.5% | -14.7% | 35.3% |
Return vs Industry: ONO exceeded the Polish Food industry which returned -14.7% over the past year.
Return vs Market: ONO underperformed the Polish Market which returned 35.3% over the past year.
Price Volatility
ONO volatility | |
---|---|
ONO Average Weekly Movement | 6.2% |
Food Industry Average Movement | 5.9% |
Market Average Movement | 5.0% |
10% most volatile stocks in PL Market | 9.5% |
10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: ONO has not had significant price volatility in the past 3 months.
Volatility Over Time: ONO's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 51 | Jacek Kostrzewa | https://onesano.pl |
onesano S.A. engages in the research and development in the areas of dietetics, animal nutrition, bioremediation, and agrotechnological processes in Poland. The company provides human dietary supplement products under the Estrovita brand. It also offers Yarrowia Equinox; Yarrowia Canifelox; and Yarrowia Farminox; and dietary supplements, food additives, functional foods, and cosmetic raw materials.
onesano S.A. Fundamentals Summary
ONO fundamental statistics | |
---|---|
Market cap | zł88.94m |
Earnings (TTM) | -zł5.21m |
Revenue (TTM) | zł13.09m |
6.8x
P/S Ratio-17.1x
P/E RatioIs ONO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ONO income statement (TTM) | |
---|---|
Revenue | zł13.09m |
Cost of Revenue | zł7.41m |
Gross Profit | zł5.68m |
Other Expenses | zł10.89m |
Earnings | -zł5.21m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 23, 2024
Earnings per share (EPS) | -0.079 |
Gross Margin | 43.38% |
Net Profit Margin | -39.83% |
Debt/Equity Ratio | 0.08% |
How did ONO perform over the long term?
See historical performance and comparison